‘You get what you pay for’ on API quality
As C2 Pharma works to expand its API portfolio, its CEO states that there is ‘no short game’ on API quality.
As C2 Pharma works to expand its API portfolio, its CEO states that there is ‘no short game’ on API quality.
Antibody-focused service providers merge their offerings to create a ‘seamless workflow’ on antibody-drug conjugates to help save developers’ time and costs.
Funding from Gamma supports the development of Univercells’ biomanufacturing platform and bioreactors, with the latter looking to expand into the fast-growing gene therapy segment.
President Trump proposes extra cash for US FDA to address “significant problems at many inspected outsourcing facilities.”